Karen A. Dawes - Feb 27, 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Feb 27, 2024
Transactions value $
$1,266
Form type
4
Date filed
2/28/2024, 09:56 PM
Previous filing
Aug 30, 2023
Next filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $195K +4.63K +5.52% $42.07 88.4K Feb 27, 2024 Direct
transaction RGEN Common Stock Sale -$193K -1K -1.13% $193.35 87.4K Feb 27, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +4.63K $0.00* 0 Feb 27, 2024 Common Stock 4.63K $42.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable.